company

FORSKNINGSFONDET FOR CYSTISK FIBROSE

1337 SANDVIKA

Return on Equity
27,12 %
Current Ratio
N/A
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue1 052 000
Net Income976 000
Total Assets3 599 000
Total Equity3 599 000
Income (NOK)2022
Revenue1 052 000
Expenditure117 000
Operating Profit935 000
Financial Income41 000
Financial Costs0
Financial Balance41 000
Earnings Before Tax976 000
Tax0
Net Income976 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets3 599 000
Total Assets3 599 000
Total Retained Equity3 599 000
Total Equity3 599 000
Total Long-Term Debt0
Total Current Debt0
Total Equity and Debt3 599 000
Cash flow (NOK)2022
Sales Income0
Other Income1 052 000
Revenue1 052 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure117 000
Operating Profit935 000
Financial Income41 000
Financial Costs0
Financial Balance41 000
Dividends0
Net Income976 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank3 599 000
Total Current Assets3 599 000
Total Assets3 599 000
Total Equity3 599 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt0
Total Equity and Debt3 599 000
Financial indicators2022
Return on Equity27,12 %
Debt-to-Equity Ratio0
Operating Profit Margin88,88 %
Current Ratio-
Quick Ratio-
Equity Ratio1
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English